Can the routine use of fluoroquinolones for community-acquired pneumonia delay the diagnosis of tuberculosis? A salutary case of diagnostic delay in a pilgrim returning from Mecca

L. Sølling Avnon; A. Jotkowitz; A. Smoliakov; D. Flusser; D. Heimer

doi:10.1016/j.ejim.2006.02.016

Can the routine use of fluoroquinolones for community-acquired pneumonia delay the diagnosis of tuberculosis? A salutary case of diagnostic delay in a pilgrim returning from Mecca

L. Sølling Avnon, A. Jotkowitz, A. Smoliakov, D. Flusser, D. Heimer

Medical School for International Health

Research output: Contribution to journal › Article › peer-review

4 Scopus citations

Abstract

Guidelines advocate using fluoroquinolones as first-line treatment for community-acquired pneumonia (CAP). However, the use of fluoroquinolones in patients with undiagnosed tuberculosis may cause a delay in the diagnosis of tuberculosis and may also promote the development of resistance to these drugs if used as monotherapy in undiagnosed tuberculosis. We illustrate the former with the following case report of a patient who developed tuberculosis after a pilgrimage to Mecca.

Original language	English
Pages (from-to)	444-446
Number of pages	3
Journal	European Journal of Internal Medicine
Volume	17
Issue number	6
DOIs	https://doi.org/10.1016/j.ejim.2006.02.016
State	Published - 1 Oct 2006

Keywords

Community-acquired pneumonia
Delay in tuberculosis diagnosis
Fluoroquinolones
Mecca pilgrimage
Mycobacterium tuberculosis

ASJC Scopus subject areas

Internal Medicine

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.ejim.2006.02.016

Cite this

@article{53d73ef753f74c199a413d2b78026a76,

title = "Can the routine use of fluoroquinolones for community-acquired pneumonia delay the diagnosis of tuberculosis? A salutary case of diagnostic delay in a pilgrim returning from Mecca",

abstract = "Guidelines advocate using fluoroquinolones as first-line treatment for community-acquired pneumonia (CAP). However, the use of fluoroquinolones in patients with undiagnosed tuberculosis may cause a delay in the diagnosis of tuberculosis and may also promote the development of resistance to these drugs if used as monotherapy in undiagnosed tuberculosis. We illustrate the former with the following case report of a patient who developed tuberculosis after a pilgrimage to Mecca.",

keywords = "Community-acquired pneumonia, Delay in tuberculosis diagnosis, Fluoroquinolones, Mecca pilgrimage, Mycobacterium tuberculosis",

author = "Avnon, {L. S{\o}lling} and A. Jotkowitz and A. Smoliakov and D. Flusser and D. Heimer",

year = "2006",

month = oct,

day = "1",

doi = "10.1016/j.ejim.2006.02.016",

language = "English",

volume = "17",

pages = "444--446",

journal = "European Journal of Internal Medicine",

issn = "0953-6205",

publisher = "Elsevier B.V.",

number = "6",

}

Can the routine use of fluoroquinolones for community-acquired pneumonia delay the diagnosis of tuberculosis? A salutary case of diagnostic delay in a pilgrim returning from Mecca. / Avnon, L. Sølling; Jotkowitz, A.; Smoliakov, A. et al.
In: European Journal of Internal Medicine, Vol. 17, No. 6, 01.10.2006, p. 444-446.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - Can the routine use of fluoroquinolones for community-acquired pneumonia delay the diagnosis of tuberculosis? A salutary case of diagnostic delay in a pilgrim returning from Mecca

AU - Avnon, L. Sølling

AU - Jotkowitz, A.

AU - Smoliakov, A.

AU - Flusser, D.

AU - Heimer, D.

PY - 2006/10/1

Y1 - 2006/10/1

N2 - Guidelines advocate using fluoroquinolones as first-line treatment for community-acquired pneumonia (CAP). However, the use of fluoroquinolones in patients with undiagnosed tuberculosis may cause a delay in the diagnosis of tuberculosis and may also promote the development of resistance to these drugs if used as monotherapy in undiagnosed tuberculosis. We illustrate the former with the following case report of a patient who developed tuberculosis after a pilgrimage to Mecca.

AB - Guidelines advocate using fluoroquinolones as first-line treatment for community-acquired pneumonia (CAP). However, the use of fluoroquinolones in patients with undiagnosed tuberculosis may cause a delay in the diagnosis of tuberculosis and may also promote the development of resistance to these drugs if used as monotherapy in undiagnosed tuberculosis. We illustrate the former with the following case report of a patient who developed tuberculosis after a pilgrimage to Mecca.

KW - Community-acquired pneumonia

KW - Delay in tuberculosis diagnosis

KW - Fluoroquinolones

KW - Mecca pilgrimage

KW - Mycobacterium tuberculosis

UR - http://www.scopus.com/inward/record.url?scp=33749984809&partnerID=8YFLogxK

U2 - 10.1016/j.ejim.2006.02.016

DO - 10.1016/j.ejim.2006.02.016

M3 - Article

AN - SCOPUS:33749984809

SN - 0953-6205

VL - 17

SP - 444

EP - 446

JO - European Journal of Internal Medicine

JF - European Journal of Internal Medicine

IS - 6

ER -

Can the routine use of fluoroquinolones for community-acquired pneumonia delay the diagnosis of tuberculosis? A salutary case of diagnostic delay in a pilgrim returning from Mecca

Abstract

Keywords

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this